Amedisys, a leading home health care and hospice company (NASDAQ: AMED), today announced that 235 of its care centers across the country have been named to the 2012 HomeCare Elite™, a compilation of the top-performing home health agencies in the United States compiled annually by OCS Home Care and DecisionHealth. Now in its seventh year, the HomeCare Elite identifies the top 25 percent of agencies and further highlights the top 100 and top 500 agencies overall. Winners are ranked by an analysis of performance measures in quality outcomes, quality improvement and financial performance.
This recognition comes during National Home Care and Hospice Month which is observed in November each year, raising awareness of the importance of home health care throughout the country.
“The 2012 HomeCare Elite winners demonstrate a commitment to providing patient-centered care and serving as leaders in the home health community. Their success offers data-driven proof of being well-managed and high quality care providers to hospitals, managed care organizations, ACOs, and other potential referral partners across the health care continuum,” said Susan L. Henricks, president and COO of National Research Corporation, the parent company of OCS HomeCare. “Again, this year, we updated our methodology to reflect the rapidly evolving quality-focused health care landscape and national value-based purchasing trends. We congratulate Amedisys on being one of the top home care agencies in the country.”
“Our mission is to provide exceptional at-home care to the communities we serve, and our team of clinical specialists takes great pride in the quality of care and service they provide,” said Kate Jones, RN, chief clinical officer of Amedisys Home Health and Hospice. “Making the 2012 HomeCare Elite list is an honor that recognizes our exceptional care teams and their commitment to meeting the greatest needs of our patients in the comfort of their own homes.”
Check Out Our Best Services for Investors
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
Access the tool that DOMINATES the Russell 2000 and the S&P 500.
- Buy, hold, or sell recommendations for over 4,300 stocks
- Unlimited research reports on your favorite stocks
- A custom stock screener
- Model portfolio
- Stocks trading below $10
- Intraday trade alerts